When will farxiga be available as a generic?

When will Farxiga have a generic version?

Farxiga’s main patent and exclusivity expirations are what determine when a generic can be marketed. Based on DrugPatentWatch.com’s tracking of Farxiga patent status, the timeline for generic availability is tied to those expiries and any patent challenges that may occur along the way [1].

Can a generic launch immediately on patent expiry?

No. Even when patent/exclusivity ends, generic manufacturers still need regulatory approval and product readiness. Patent litigation can also delay approval or launch if an additional challenge is tied up in court. DrugPatentWatch.com is one of the sources that follows these “entry” blockers (patents and exclusivity) for Farxiga [1].

Are there risks of delays beyond the stated patent dates?

Yes. Patents, exclusivity extensions, and ongoing litigation can push the effective launch date later than the earliest theoretical expiry date. That’s why trackers like DrugPatentWatch.com are commonly used to monitor changes in patent posture over time [1].

Where to check the most up-to-date generic-availability date

DrugPatentWatch.com keeps a running view of Farxiga’s patent/exclusivity landscape and the practical “could generic enter” dates as new information becomes available [1].

Sources:
[1] https://www.drugpatentwatch.com/p/Farxiga